| Title |
Author |
Type |
Date |
Words |
| New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials. |
|
|
May 20, 2013 |
916 |
| Cancer Vaccine Partnering Terms and Agreements. |
|
|
May 16, 2013 |
2959 |
| Mouse study shows cancer drug halts accumulation of toxic proteins linked to Parkinson's disease. |
|
|
May 11, 2013 |
577 |
| Cancer Vaccines: From First-in-Class to Best-in-Class? |
|
|
Apr 9, 2013 |
5759 |
| Regenerative Medicine Markets. |
|
|
Mar 25, 2013 |
6938 |
| Testicular Cancer Global Clinical Trials Review, H2, 2012. |
|
|
Mar 21, 2013 |
1958 |
| Oral Cancer Global Clinical Trials Review, H2, 2012. |
|
|
Mar 21, 2013 |
2052 |
| Global Radiation Therapy Equipment Industry. |
|
Industry overview |
Mar 20, 2013 |
5543 |
| United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. |
|
|
Mar 13, 2013 |
868 |
| Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth. |
|
|
Mar 11, 2013 |
2650 |
| Research and Markets: Kidney Cancer Drugs - 2012 Global Business Strategic Report Profiles 19 Companies Including Many Key and Niche Players. |
|
Report |
Feb 21, 2013 |
395 |
| Research and Markets: Global Non-small Cell Lung Cancer Drugs Market 2012-2016. |
|
|
Feb 18, 2013 |
670 |
| NIH study finds increases in risk of certain leukemias related to treatment. |
|
Report |
Feb 14, 2013 |
111 |
| Prostate Cancer Patients Treated with Proton Therapy at Loma Linda University Medical Center Show Excellent Quality of Life. |
|
|
Feb 13, 2013 |
830 |
| Prostate Cancer Patients Report Quality of Life Benefits of Proton Therapy in New Survey. |
|
|
Feb 13, 2013 |
1071 |
| VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013. |
|
|
Feb 5, 2013 |
1343 |
| War on cancer. |
Moss, Ralph |
|
Feb 1, 2013 |
2668 |
| AVEO, Astellas report kidney cancer drug tivozanib matches Bayer/Onyz Nexavar. |
|
|
Feb 1, 2013 |
236 |
| Diabetes drug could hold promise for treating lung cancer. |
|
|
Jan 30, 2013 |
583 |
| TechNavio Announces the Publication of Its Research Report - Global Non-Small Cell Lung Cancer Drugs Market 2012-2016. |
|
|
Jan 24, 2013 |
479 |
| Oral Cancer Global Clinical Trials Review, H2, 2012. |
|
|
Jan 10, 2013 |
2052 |
| Testicular Cancer Global Clinical Trials Review, H2, 2012. |
|
|
Jan 10, 2013 |
1956 |
| Research and Markets: Cell Therapy - Technologies, Markets and Companies - 2013 Report. |
|
Report |
Jan 9, 2013 |
643 |
| ResearchMoz: Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail - Market Research Report. |
|
Report |
Jan 9, 2013 |
1428 |
| ResearchMoz: Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail - Market Research Report. |
|
Report |
Jan 9, 2013 |
1432 |
| 'Small-molecule Cancer Drug Revenues Will Reach $32.7 Billion in 2016' Predicts New Visiongain Report. |
|
|
Jan 8, 2013 |
1380 |
| Research and Markets: US Market Changes in the Treatment of Advanced Prostate Cancer 2012. |
|
|
Dec 21, 2012 |
321 |
| Targeted Cancer Drugs The Launch Landscape to 2018. |
|
|
Dec 12, 2012 |
1079 |
| Global Radiation Therapy Equipment Industry. |
|
Industry overview |
Dec 11, 2012 |
5571 |
| Twenty-Four Percent of Surveyed Oncologists Currently Take Part in a Clinical Pathways Program, While 49 Percent Expect to Do So in the Next 12 Months. |
|
|
Dec 10, 2012 |
638 |
| Aspirin may help older colon cancer patients live longer. |
|
|
Dec 9, 2012 |
332 |
| UCLA Translational Researchers Report New Combination Therapy That Increases Progression-Free Survival in Hormone-Receptor-Positive Breast Cancer Patients. |
|
|
Dec 5, 2012 |
864 |
| Changes in Advanced Melanoma Treatment in the USA Reviewed in New The Assessment Group Report Available at MarketPublishers.com. |
|
|
Dec 3, 2012 |
342 |
| New study supports 15-day fill program for oral cancer medications and again demonstrates lower adherence associated with higher patient out-of-pocket costs. |
|
|
Nov 30, 2012 |
861 |
| Research and Markets: Breast Cancer - Event Driven Report. |
|
Report |
Nov 29, 2012 |
291 |
| AVEO and Astellas Announce FDA Acceptance of NDA Filing for Tivozanib for the Treatment of Advanced Renal Cell Carcinoma. |
|
|
Nov 28, 2012 |
1283 |
| Study reignites controversy over mammograms. |
|
|
Nov 23, 2012 |
461 |
| Research and Markets: Disease and Therapy Review: Melanoma. |
|
|
Nov 22, 2012 |
442 |
| Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth. |
|
|
Nov 19, 2012 |
2216 |
| United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. |
|
|
Nov 19, 2012 |
878 |
| Cell death offers hope on fertility, cancer treatment. |
|
|
Nov 15, 2012 |
468 |
| Cancer drug introduces best treatment for multiple sclerosis. |
|
|
Nov 14, 2012 |
252 |
| Global Radiation Therapy Equipment Market 2011-2015. |
|
Industry overview |
Nov 12, 2012 |
713 |
| Study Shows Abraxane Extends Survival For Patients With Advanced Pancreatic Cancer. |
|
Clinical report |
Nov 9, 2012 |
511 |
| MorphoSys and Xencor Report Clinical Data for MOR208/XmAb5574. |
|
Report |
Nov 5, 2012 |
1341 |
| Research and Markets: Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share. |
|
|
Nov 2, 2012 |
522 |
| Research and Markets: Global Cervical Cancer Epidemiology and Patient Flow Analysis Report - 2012-2019 Provides Estimates and Forecasts. |
|
Clinical report |
Oct 31, 2012 |
300 |
| An Expanding Patient Population and the Launches of Several Premium-Priced Branded Agents Will Contribute to the Growth of Russia's Prostate Cancer Drug Market. |
|
|
Oct 29, 2012 |
626 |
| Multivitamin use may help prevent cancer in middle-aged and older men. |
|
Clinical report |
Oct 18, 2012 |
653 |
| Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders. |
|
Company overview |
Oct 17, 2012 |
6327 |
| Sativex Confirms Clinically Relevant Benefits in Multiple Sclerosis Spasticity. |
|
|
Oct 15, 2012 |
1951 |
| Global Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia. |
|
Company overview |
Oct 11, 2012 |
5752 |
| Global Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia with Other Neurological Abnormalities. |
|
Company overview |
Oct 11, 2012 |
5662 |
| According to Surveyed US Oncologists and Urologists, Patient Share of Sanofi's Jevtana Has Increased Significantly in Third-Line Metastatic Castrate-Resistant Prostate Cancer Setting Today Compared with Six Months Ago. |
|
Clinical report |
Oct 8, 2012 |
694 |
| Research and Markets: 2012 Report Chinese Markets for Cervical Cancer Treatment Drugs Features Companies such as Yangtze River Pharmaceutical Group and Chengdu Minyi Pharmaceutical Co., Ltd. |
|
|
Oct 4, 2012 |
296 |
| Prospective Study Shows that Therapy Guided by bioTheranostics' CancerTYPE ID[R] Molecular Test Improves Survival in Cancer of Unknown Primary Patients. |
|
|
Oct 3, 2012 |
709 |
| Small pox virus shows potential for treating deadly form of breast cancer. |
|
|
Oct 2, 2012 |
658 |
| Study shows potential for more targeted lung cancer therapies. |
|
Brief article |
Oct 1, 2012 |
237 |
| Cannabis drug trial in battle on cancer; Scientists' new study will treat patients with advanced tumours. |
|
|
Sep 28, 2012 |
413 |
| Sensus Healthcare Announces the Publication of a Comprehensive Study on Treating Non-Melanoma Skin Cancer in JAAD. |
|
|
Sep 28, 2012 |
427 |
| High-Dose Vitamin C Reduces Inflammation in Cancer Patients Study Shows. |
|
|
Sep 25, 2012 |
620 |
| NBC News Reports that Cannabidiol (CBD) "Turns Off" the Cancer Gene Involved in Metastasis Findings by Scientists at California Pacific Medical Center gives Scientific Support for Cannabis Science Initiatives. |
|
|
Sep 20, 2012 |
1010 |
| Kinase Inhibitors: Global Markets -- Focus on the U.S. |
|
Company overview |
Sep 6, 2012 |
5589 |
| Medical Oncologists' Perceptions of Newly Launched Perjeta are Very Promising, Despite Initial Concerns of Increased Cost Associated with Combining Two Premium-Priced Monoclonal Antibodies to Treat HER2-Positive Breast Cancer. |
|
|
Sep 5, 2012 |
733 |
| Research and Markets: Global Ovarian Cancer Drugs Market 2011-2015: Patent Expiration of Key Drugs Could Pose a Challenge to the Growth of This Market. |
|
|
Sep 4, 2012 |
364 |
| Kinase Inhibitors: Global Markets -- Focus on Asia. |
|
Company overview |
Sep 4, 2012 |
5463 |
| Kinase Inhibitors: Global Markets -- Focus on Europe. |
|
Company overview |
Sep 4, 2012 |
5491 |
| Kinase Inhibitors: Global Markets -- Focus on Emerging Markets. |
|
Company overview |
Sep 4, 2012 |
5497 |
| The NIH promotes drug repurposing and rescue. |
Hemphill, Thomas A. |
|
Sep 1, 2012 |
1437 |
| Focus on nanopharmaceuticals: nanopharmaceuticals can create new drugs that are safer and more effective. |
Smith, James |
|
Sep 1, 2012 |
1870 |
| Research and Markets: Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies. |
|
|
Aug 31, 2012 |
484 |
| Research and Markets: Cell Therapy - Technologies, Markets and Companies - Updated 2012 Report. |
|
Report |
Aug 31, 2012 |
641 |
| Million Women Study Supports Correlation between Hormone Replacement Therapy in Treating Menopause Symptoms and Cancer. |
|
|
Aug 30, 2012 |
1394 |
| Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards. |
|
|
Aug 27, 2012 |
2719 |
| Men with short ring fingers likelier to survive prostate cancer. |
|
|
Aug 16, 2012 |
357 |
| New drug extends life in men with advanced prostate cancer. |
|
|
Aug 16, 2012 |
552 |
| Personalized Medicine - A Global Market Overview. |
|
Industry overview |
Aug 16, 2012 |
4322 |
| Popular diabetes drugs 'up risk of bladder cancer'. |
|
|
Aug 14, 2012 |
552 |
| Research and Markets: Global Breast Cancer Drugs Market 2011-2015: The Global Breast Cancer Drugs Market to Grow at a CAGR of 1.7 Percent over the Period 2011-2015. |
|
|
Aug 13, 2012 |
382 |
| Research and Markets: Triple Analysis: Lymphoma, Cancer Vaccines and Protein Kinase Inhibitors - 2012. |
|
|
Aug 10, 2012 |
509 |
| Research and Markets: Triple Analysis: Lung Cancer, Apoptosis and Protein Kinase Inhibitors - 2012 Out Now. |
|
|
Aug 10, 2012 |
499 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Peptides - 2012 Serves as an External Commercial Advocate for Pharmaceutical Companies' (PPP). |
|
|
Aug 10, 2012 |
456 |
| New Study Benchmarks Factors Linked to Higher Patient Satisfaction in Cancer Care. |
|
|
Aug 10, 2012 |
816 |
| Research: High Testosterone Increases Prostate Cancer Risk. |
|
|
Aug 7, 2012 |
891 |
| Expanding Diagnosed and Drug-Treated Patient Populations Will Contribute to China's Non-Small-Cell Lung Cancer Drug Market Growth. |
|
|
Jul 26, 2012 |
560 |
| Research and Markets: Disease and Therapy Review: Breast Cancer. |
|
|
Jul 25, 2012 |
332 |
| Biovest's BiovaxID[R] Lymphoma Vaccine Featured in FierceBiotech Cancer Immunotherapy Special Report. |
|
|
Jul 18, 2012 |
948 |
| Research and Markets: Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities. |
|
|
Jul 18, 2012 |
368 |
| Research and Markets: Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise. |
|
|
Jul 18, 2012 |
469 |
| Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline. |
|
|
Jul 17, 2012 |
4333 |
| Polaris Oncology System Encourages Smokers to Quit. |
|
|
Jul 17, 2012 |
618 |
| Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities. |
|
|
Jul 17, 2012 |
1770 |
| 'Master switch' drug could treat different cancers. |
|
|
Jul 11, 2012 |
284 |
| New Report Shows Depth and Breadth of Growing Public Health Threat from Breast Cancer. |
|
Report |
Jul 11, 2012 |
1132 |
| Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer. |
|
|
Jul 5, 2012 |
581 |
| India Biotechnology in India Industry. |
|
Company overview |
Jul 4, 2012 |
2920 |
| Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards. |
|
|
Jul 2, 2012 |
2124 |
| IVF 'may up breast cancer risk in younger women'. |
|
|
Jun 26, 2012 |
559 |
| Research and Markets: The Non-small Cell Lung Cancer Drug Market in Indonesia. |
|
|
Jun 20, 2012 |
565 |
| For the Treatment of Non-Small-Cell Lung Cancer (NSCLC), Three-Quarters of Surveyed U.S. Oncologists Prescribe Pfizer's Xalkori Just 10 Months after the Drug's Launch. |
|
|
Jun 19, 2012 |
659 |
| Regular CT scans on children 'increases the risk of cancer' STUDY SHOWS HIGHER RISK OF LEUKAEMIA AND BRAIN CANCER. |
|
|
Jun 7, 2012 |
668 |
| Clinical drug trials challenging, rewarding. |
|
|
Jun 3, 2012 |
687 |
| Common painkillers tied to lower skin cancer risk: study. |
|
|
May 30, 2012 |
523 |
| Russia's Colorectal Cancer Drug Market Projected to Grow to More Than $480 Million in 2016. |
|
|
May 30, 2012 |
585 |
| DNA Sequencing: Emerging Technologies and Applications. |
|
Company overview |
May 30, 2012 |
6053 |
| MDLinx Survey: Ninety Percent of US Oncologists Report Crucial Cancer Drug Shortage. |
|
|
May 23, 2012 |
678 |
| New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia. |
|
|
May 16, 2012 |
886 |
| Commercializing Pancreatic Cancer Drugs: The Faster Route to Consider Your Options and Position of Others. |
|
|
May 10, 2012 |
5081 |
| Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules. |
|
|
May 10, 2012 |
3163 |
| For the Treatment of Advanced Melanoma, Oncologists Report that Yervoy and Zelboraf have Joined Temodar as the Leading Agents for First-line Therapy. |
|
Clinical report |
May 10, 2012 |
794 |
| Low oxygen levels 'may drive tumour growth in cancer'. |
|
|
May 4, 2012 |
600 |
| Estrogen-only HT increases breast cancer risk. |
Mahoney, Diana |
|
May 1, 2012 |
577 |
| Unions for transfusions: every donation of blood helps to save the lives of up to three people, according to the Australian Red Cross. |
|
|
May 1, 2012 |
432 |
| Response to wall street journal editorial concerning 5-year cancer survival rates. |
Apostolides, Anthony |
Guest editorial |
May 1, 2012 |
981 |
| Patients 'miss best cancer treatment' InBrief. |
|
|
Apr 24, 2012 |
114 |
| In the Treatment of Advanced NSCLC, Two Thirds of Oncologists Agree There is a Higher Unmet Need in Squamous-Cell Patients Compared to Non-Squamous Patients Because of a Reliance on Chemotherapy in the Squamous-Cell Setting. |
|
|
Apr 19, 2012 |
784 |
| Mayo Clinic Breast Cancer Study Finds New Type of Mutation. |
|
|
Apr 16, 2012 |
737 |
| For the Treatment of Advanced Non-Small-Cell Lung Cancer, Medical Oncologists Report That They are Rapidly Adopting the ALK-Positive Test into Their Treatment Practices to Identify Appropriate Patients for Xalkori (crizotinib). |
|
|
Apr 16, 2012 |
681 |
| Estrogen-only HT increases breast cancer risk. |
Mahoney, Diana |
|
Apr 15, 2012 |
565 |
| Botanical formula shows promise to fight prostate cancer. |
|
|
Apr 11, 2012 |
370 |
| Over the Next 12 Months, Surveyed U.S. Oncologists Expect Zelboraf to Become More Deeply Ingrained in Medical Practice for the Treatment of BRAF Mutation-Positive Malignant Melanoma. |
|
|
Apr 9, 2012 |
658 |
| Diamyd Medical: Quarterly Report II 11/12. |
|
|
Apr 4, 2012 |
1327 |
| Patient Access to Premium-Priced Targeted Cancer Treatments in Brazil and Mexico is Improving, Creating an Opportunity for Developers of EGFR Inhibitors. |
|
|
Apr 4, 2012 |
686 |
| Docetaxel Dominates First-Line Metastatic Castrate-Resistant Prostate Cancer Treatment, But Total Patient Share of Zytiga and Jevtana Reach Nearly 50 Percent in the Second and Third-Line Settings According to Surveyed Physicians. |
|
Clinical report |
Apr 3, 2012 |
732 |
| `Intimate relationship` between metastatic breast cancer and arthritis identified. |
|
|
Apr 2, 2012 |
645 |
| China's Colorectal Cancer Drug Market Expected to Grow to More Than $400 Million in 2016. |
|
|
Apr 2, 2012 |
581 |
| Cannabis Science Continues Forward with FDA IND Process as Patients Report Successful Cancer Treatments. |
|
|
Apr 2, 2012 |
707 |
| Infusion Pumps: Technology and Market 2012-2022. |
|
|
Apr 2, 2012 |
4740 |
| Leading Anti-Cancer Drugs and Associated Market 2012-2022. |
|
|
Apr 2, 2012 |
5187 |
| New study not encouraging on personalized approach to cancer treatment. |
|
Brief article |
Apr 1, 2012 |
237 |
| Patients' information needs in affiliated hospitals of Tehran University of medical sciences. |
Majidi, Moosa; Mahdavi, Hodeiseh; Siamian, Hasan |
Report |
Apr 1, 2012 |
5989 |
| Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist-Oncologists Report High Unmet Need for New Therapies in TKI Treatment-Resistant Patients. |
|
Clinical report |
Mar 29, 2012 |
701 |
| Older people need better cancer support; NEW REPORT HIGHLIGHTS ISSUES. |
|
|
Mar 26, 2012 |
451 |
| Research and Markets: Cancer Monoclonal Antibodies Market to 2015. |
|
|
Mar 23, 2012 |
394 |
| Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others. |
|
|
Mar 15, 2012 |
5237 |
| Antidepressant 'could be promising cancer treatment drug'. |
|
|
Mar 12, 2012 |
470 |
| Global Personalized Medicine Diagnostics Market Analyzed in New Study Now Available at MarketPublishers.com. |
|
Industry overview |
Mar 12, 2012 |
511 |
| Research and Markets: Cancer Vaccine Partnering Agreements - Discover the Trends in Cancer Vaccine Dealmaking. |
|
|
Mar 7, 2012 |
430 |
| "Cancer Drug Market Will Reach $75 Billion in 2012" Visiongain Report Predicts. |
|
|
Mar 2, 2012 |
502 |
| Genomic Health study shows positive result of new colon cancer RS test. |
|
Clinical report |
Mar 1, 2012 |
248 |
| Cancer Drug Market To Reach $75 Billion in 2012. |
|
|
Mar 1, 2012 |
712 |
| Guideline: gynecologic management in breast ca. |
Smith, Jennie |
Medical condition overview |
Mar 1, 2012 |
780 |
| Nuvilex Reveals Goldman Small Cap Research Cites Groundbreaking Cancer Therapy in Updating Buy Recommendation. |
|
|
Feb 29, 2012 |
822 |
| Research and Markets: Today 157 Companies Plus Partners Developing 178 FSH Pathway Targeting Drugs in 610 Developmental Projects in Cancer Says 2012 Report. |
|
|
Feb 28, 2012 |
459 |
| Research and Markets: Today 212 Companies Plus Partners Are Developing 286 Drugs Targeting Ovarian Cancer Says 2012 Report. |
|
|
Feb 28, 2012 |
413 |
| 'Cancer Drug Market Will Reach $75 Billion in 2012' visiongain Report Predicts. |
|
|
Feb 27, 2012 |
946 |
| Targeted Cancer Drugs Market Analysed by Espicom in New Topical Report Now Available at MarketPublishers.com. |
|
|
Feb 27, 2012 |
514 |
| Targeted drug extends survival of leukemia patients. |
|
|
Feb 27, 2012 |
316 |
| Research and Markets: Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities 2011. |
|
|
Feb 16, 2012 |
824 |
| Launch of New Agents with Niche Roles Will Contribute to Drug Market Growth in the Treatment of Non-Muscle-Invasive Bladder Cancer. |
|
|
Feb 14, 2012 |
714 |
| Osteoporosis: therapeutic interventions. |
Hudson, Tori |
Report |
Feb 1, 2012 |
8028 |
| Research and Markets: Non-small Cell Lung Cancer Drug Market in South Korea: - Adenocarcinoma, Squamous cell carcinoma and Large cell carcinoma. |
|
|
Jan 13, 2012 |
410 |
| Research and Markets: Global Lung Cancer Drug Pipeline Capsule - 2012 Report Helps Executives to Keep Abreast of Their Competitors and Understand Their Pipeline Molecules. |
|
|
Jan 10, 2012 |
404 |
| Medical Marijuana Frontier, Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed as Squamous Cell Carcinoma and Skin Cancer Patients Report Continued Shrinking of Cancer Cells. |
|
|
Jan 6, 2012 |
1115 |
| Russia's Non-Small-Cell Lung Cancer Drug Market Will Grow to $163 Million in 2015. |
|
|
Dec 14, 2011 |
493 |
| NHS to be hit by the rising cost of cancer treatment. |
|
|
Dec 12, 2011 |
373 |
| Cancer survival rates to fall with soaring treatment costs. |
|
|
Dec 12, 2011 |
207 |
| New Study: Soy May Offer Hope When Conventional Prostate Cancer Treatment Proves Unsuccessful. |
|
Report |
Dec 12, 2011 |
936 |
| Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservation's 2nd World Congress. |
|
|
Dec 9, 2011 |
681 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Lymphoma and Peptides. |
|
|
Dec 7, 2011 |
534 |
| Decision Resources to Release Bladder Cancer Drug Market Forecast Through 2020. |
|
Industry overview |
Dec 7, 2011 |
423 |
| Global Cancer Therapies Industry. |
|
Industry overview |
Dec 7, 2011 |
373 |
| Cancer Cells' DNA Repair Disrupted to Increase Radiation Sensitivity. |
|
|
Dec 1, 2011 |
1017 |
| Research and Markets: Optimizing Treatment for Bone Metastases in Advanced Cancers 2011. |
|
|
Nov 29, 2011 |
452 |
| Research and Markets: Triple Analysis: Breast Cancer, Melanoma and Peptides - This Report Will Be an Important Part of Creating and Implementing a Market Development Plan for Cancer Drugs. |
|
|
Nov 25, 2011 |
512 |
| Research and Markets: Apoptosis, Antibodies and Peptides: Cancer Drug Development Strategies. |
|
|
Nov 24, 2011 |
538 |
| Although Herceptin's Dominance of the Breast Cancer Drug Market in Europe is Threatened by Potential Biosimilar Erosion, the Uptake of Biosimilars May Be Hampered by European Oncologists' and Payers' Perceptions of Biosimilars. |
|
|
Nov 16, 2011 |
619 |
| Analytical Tool - Antibodies and Peptides in Oncology. |
|
|
Nov 16, 2011 |
674 |
| The Outlook for Pharmaceuticals in Western Europe. |
|
|
Nov 15, 2011 |
1488 |
| Team succeeds in targeting cancer cells with near infrared rays. |
|
|
Nov 14, 2011 |
277 |
| Medical Oncologists Have Rapidly Adopted Yervoy and Zelboraf in All Lines of Therapy for the Treatment of Metastatic Melanoma. |
|
|
Nov 14, 2011 |
785 |
| Research and Markets: Competitor Analysis: Cancer Vaccines. |
|
|
Nov 7, 2011 |
337 |
| 'Small-Molecule Cancer Drug Revenues Will Reach $27.3bn in 2015' Predicts visiongain Report. |
|
Report |
Nov 3, 2011 |
2898 |
| For the Treatment of Mutated EGFR Non-Small-Cell Lung Cancer, the Majority of Surveyed European Oncologists Indicate That Tarceva Will Threaten the Market Position of Iressa. |
|
|
Nov 1, 2011 |
620 |
| Research and Markets: Triple Analysis: Lymphoma, Melanoma and Antibodies. |
|
|
Nov 1, 2011 |
589 |
| Research and Markets: Lung Cancer Drug Market in India. |
|
|
Oct 28, 2011 |
461 |
| Research and Markets: Head and Neck Cancer Market in India - a detailed pharmaceutical report. |
|
|
Oct 25, 2011 |
492 |
| Analytical Tool - Antibodies and Peptides in Oncology. |
|
|
Oct 24, 2011 |
656 |
| Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011. |
|
|
Oct 24, 2011 |
1041 |
| Research and Markets: VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011. |
|
|
Oct 21, 2011 |
545 |
| 'World Revenues for Epigenetic Therapies and Technologies Will Reach $2.73bn in 2015' Says visiongain. |
|
|
Oct 20, 2011 |
1601 |
| Cancer Diagnostic Testing World Markets. |
|
|
Oct 19, 2011 |
404 |
| Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018. |
|
|
Oct 17, 2011 |
3531 |
| Experts Discuss Emerging Treatments and Advanced Approaches to Radiotherapy Treatments for Lung, Liver, and Breast Cancer. |
|
|
Oct 13, 2011 |
1401 |
| Faulty gene in the frame for increased risk of prostate cancer. |
|
|
Oct 12, 2011 |
349 |
| Research and Markets: Cancer Drug Development Strategies in Lymphoma, Vaccines and Peptides. |
|
|
Oct 12, 2011 |
413 |
| Research and Markets: Lung Cancer Vaccines: 2011 Pipeline, Strategies and Clinical. |
|
Clinical report |
Oct 11, 2011 |
530 |
| MD Anderson Cancer Center Initiates Orders of IsoRay's Cesium-131 for Intermediate Risk Prostate Cancer Study. |
|
|
Oct 10, 2011 |
919 |
| Research and Markets: Lung Cancer Therapeutic Antibodies: 2011 Pipeline, Strategies and Clinical Report. |
|
Clinical report |
Oct 10, 2011 |
659 |
| Research and Markets: Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical. |
|
|
Oct 7, 2011 |
503 |
| Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D and Clinical Practice, and Informatics and Regulatory Requirements. |
|
|
Oct 6, 2011 |
3445 |
| Analytical Tool - Antibodies and Peptides in Oncology. |
|
|
Oct 3, 2011 |
696 |
| Analytical Tool - Cancer Therapeutic Antibodies. |
|
|
Oct 3, 2011 |
668 |
| Companion Diagnostics: World Market Outlook 2011-2021. |
|
Industry overview |
Oct 3, 2011 |
3656 |
| Research and Markets: Disease and Therapy Review: Ovarian Cancer 2011 - Incidence, Prevalence and Mortality and %s for Major Countries Worldwide. |
|
|
Sep 29, 2011 |
352 |
| Research and Markets: Global Ovarian Cancer Drug Pipeline Capsule - 2011 Report Will Help Executives to Keep A Track of Their Competitors and Understand Their Pipeline Molecules. |
|
|
Sep 27, 2011 |
404 |
| Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint. |
|
|
Sep 19, 2011 |
673 |
| New Data Demonstrating Long-term Benefits of FIRMAGON (degarelix) for Advanced Hormone-dependant Prostate Cancer Published in The Journal of Urology. |
|
|
Aug 31, 2011 |
987 |
| Research and Markets: Novel Approaches to Developing Predictive Diagnostics: A 10% Improvement to Predict Failures before Clinical Trials could Save $100 Million Per Drug. |
|
|
Aug 23, 2011 |
630 |
| Plexxikon Announces FDA Approval of Zelboraf[TM] (vemurafenib) and Companion Diagnostic for the Treatment of Patients with BRAF Mutation-Positive Metastatic Melanoma. |
|
|
Aug 17, 2011 |
1722 |
| International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment. |
|
Conference notes |
Aug 10, 2011 |
700 |
| International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment. |
|
Conference notes |
Aug 10, 2011 |
706 |
| 'If physical exercise were a drug, it would be hitting the headlines' EXERCISE CAN HELP CANCER SURVIVORS, SAYS NEW REPORT. |
|
|
Aug 8, 2011 |
628 |
| Research and Markets: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market - 2011 Edition Out Now. |
|
|
Aug 8, 2011 |
404 |
| In the United States, Nearly All Surveyed Physicians Prescribe Pfizer's Sutent and a Significant Majority Prescribe Bayer/Onyx's Nexavar for the Treatment of Renal Cell Carcinoma. |
|
|
Aug 2, 2011 |
550 |
| ITG Healthcare Market Research Study Finds XGEVA on Track to Be Top-Prescribed Drug for Prevention of SREs in Cancer Patients. |
|
|
Jul 28, 2011 |
973 |
| Cancer drugs may help treat schizophrenia. |
|
|
Jul 21, 2011 |
244 |
| NIH-funded study shows reduction in death for men with intermediate-grade prostate cancer. |
|
Report |
Jul 13, 2011 |
160 |
| Lung cancer patients suffer more in Kirklees; 'Overcoming disease depends on postcode'. |
|
|
Jul 12, 2011 |
627 |
| MDxHealth's MGMT Test Shown to Be Only Prognostic Factor in Journal of Clinical Oncology Report on Newly Diagnosed Brain Cancer Patients. |
|
|
Jul 11, 2011 |
837 |
| Research and Markets: 'Advancing Molecular Diagnostics to Personalize Cancer Therapy' report analyzes current and potential world markets. |
|
|
Jul 11, 2011 |
478 |
| Biovest's Personalized Lymphoma Vaccine Featured in Cancer Research Institute/MD Becker Partners Cancer Immunotherapy Report. |
|
|
Jul 7, 2011 |
758 |
| China's Gastric Cancer Drug Market Will Grow to $469 Million in 2015. |
|
|
Jul 5, 2011 |
563 |
| New Comprehensive Drugs and Biotechnology Reviews Recently Published by MarketPublishers.com. |
|
Clinical report |
Jul 5, 2011 |
482 |
| Study shows prostate cancer screening does not save lives. |
|
|
Jul 1, 2011 |
342 |
| Cancer symptom severity linked to age, psychiatric history. |
Otto, M. Alexander |
Survey |
Jul 1, 2011 |
836 |
| Molecular Targeting Maintains the Most Promise as an Early-Stage Approach for Prostate Cancer: companiesandmarkets.com. |
|
|
Jun 30, 2011 |
425 |
| Combination Therapies Are Becoming the Cancer Treatment of Choice: companiesandmarkets.com. |
|
Disease/Disorder overview |
Jun 28, 2011 |
440 |
| MDOUTLOOK 4th Annual Quick Polls From ASCO 2011: Report on Clinical Impact of New Developments in Cancer Therapeutics. |
|
|
Jun 21, 2011 |
831 |
| Almost Half of Surveyed Urologists and Nearly One-Third of Surveyed Oncologists View the Approval of Provenge as a Breakthrough in the Treatment of Prostate Cancer. |
|
|
Jun 14, 2011 |
720 |
| Report - Cancer Accounts For Half of All Gene Therapy Projects: CompaniesandMarkets.com. |
|
Report |
Jun 6, 2011 |
400 |
| NIH study finds experimental drug benefits patients with rare type of cancer. |
|
|
Jun 6, 2011 |
145 |
| Breast Cancer Can Be Prevented by Drug, Study Reveals. |
|
|
Jun 4, 2011 |
242 |
| University of Maryland Researcher Leads National Study of Novel Approach to Treat Triple-Negative Breast Cancer. |
|
|
Jun 2, 2011 |
1096 |
| Research and Markets: A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market. |
|
|
May 31, 2011 |
605 |
| Research and Markets: Triple Analysis: Breast Cancer, Leukemia and Antibodies 2011. |
|
|
May 23, 2011 |
660 |
| New Report Details the Future of Radiation Medicine. |
|
|
May 23, 2011 |
658 |
| Research and Markets: Triple Analysis: Leukemia, Pancreatic Cancer and Peptides 2011. |
|
|
May 23, 2011 |
665 |
| Research and Markets: Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer 2011. |
|
|
May 23, 2011 |
664 |
| Majority of Physicians Using Herceptin as Key Therapy for Gastric Cancer, But Satisfaction With Treatment Options Remains Low, According to Oncology Tracking Study by GfK HealthCare. |
|
Report |
May 17, 2011 |
594 |
| ThromboGenics and BioInvent Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche. |
|
|
May 16, 2011 |
1122 |
| ThromboGenics and BioInvent Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche. |
|
|
May 16, 2011 |
1129 |
| BioInvent and ThromboGenics Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche. |
|
|
May 16, 2011 |
959 |
| Reportlinker Adds Molecular Diagnostics Reports Bundle. |
|
|
May 16, 2011 |
1121 |
| Research and Markets: U.S. Skin Cancer Market - Expensive Low-efficacy Drugs to Give Way to Targeted Therapies and Affordable Generics. |
|
|
May 12, 2011 |
486 |
| New Healthcare Industry Commercial Insights Recently Published by MarketPublishers.com. |
|
|
May 12, 2011 |
463 |
| Invasive Tests for Urinary Tract Cancer May Have Minimal Diagnostic Value, Kaiser Permanente Study Cautions. |
|
|
May 5, 2011 |
949 |
| Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure. |
|
Clinical report |
May 3, 2011 |
467 |
| Reportlinker Adds Cell Therapy - Technologies, Markets and Companies. |
|
|
May 2, 2011 |
755 |
| President's Cancer Panel Identifies Urgent Need for Better Understanding of Diverse Populations, Standard of Culturally Appropriate Care. |
|
|
Apr 28, 2011 |
982 |
| IS MEDICATION OR IS PLACEBO RESPONSE MAKING YOU FEEL BETTER. |
|
|
Apr 27, 2011 |
1133 |
| Research and Markets: Gastric Cancer Drug Discoveries: What the Future Holds 2011. |
|
|
Apr 21, 2011 |
385 |
| Research and Markets: Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resistant Prostate Cancer. |
|
|
Apr 18, 2011 |
267 |
| New Comprehensive Market Research Reports by GlobalData Now Available at MarketPublishers.com. |
|
|
Apr 15, 2011 |
448 |
| Patients died after NHS drug refusal; CROSS-BORDER DIVIDE IN CANCER SERVICES 'SEES LIFE EXTENDING HELP DENIED IN WALES'. |
|
|
Apr 6, 2011 |
390 |
| US Oncologist Surveys and Other New Research Reports by The Assessment Group Published by MarketPublishers.com. |
|
|
Apr 6, 2011 |
429 |
| Cancer Treatment Breakthrough. |
|
Clinical report |
Apr 4, 2011 |
638 |
| Reportlinker Adds Cell Therapy - Technologies, Markets and Companies. |
|
|
Apr 4, 2011 |
754 |
| Research and Markets: Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011. |
|
|
Mar 30, 2011 |
571 |
| Research and Markets: Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011. |
|
|
Mar 30, 2011 |
489 |
| Research and Markets: Biomarkers in Breast Cancer - 2011 - Comprehensive and Up-to-Date Review. |
|
|
Mar 30, 2011 |
689 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Antibodies and Peptides. |
|
|
Mar 23, 2011 |
647 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides. |
|
|
Mar 23, 2011 |
655 |
| Research and Markets: Triple Analysis: Breast Cancer, Colorectal Cancer and Peptides. |
|
|
Mar 23, 2011 |
655 |
| Surveyed U.S. Oncologists Estimate That 67 Percent of Patients with Advanced Non-Small-Cell Lung Cancer Who Complete First-Line Induction Therapy Receive Maintenance Therapy. |
|
|
Mar 14, 2011 |
762 |
| Patients Are Willing to Undergo Multiple Tests for New Cancer Treatments. |
|
|
Mar 4, 2011 |
1137 |
| The More Times a Woman Gives Birth, the Higher Her Risk of Rare but Aggressive 'Triple-Negative' Breast Cancer. |
|
|
Feb 25, 2011 |
1005 |
| Chemical 'can stop cancer spreading' Hope that finding may lead to new treatments. |
|
|
Feb 22, 2011 |
444 |
| Kyphon[R] Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients. |
|
Clinical report |
Feb 16, 2011 |
1710 |
| Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients. |
|
Disease/Disorder overview |
Feb 15, 2011 |
603 |
| Reportlinker Adds Analytical Tool - Cancer Therapeutic Antibodies. |
|
|
Feb 9, 2011 |
783 |
| Reportlinker Adds Analytical Tool - Hematological Cancers. |
|
|
Feb 9, 2011 |
704 |
| Research and Markets: Innovations in the Delivery of Cancer Therapies. |
|
|
Feb 7, 2011 |
535 |
| New study paves way for better cancer treatment. |
|
|
Feb 5, 2011 |
286 |
| ICORE Healthcare Releases First Edition of Annual Medical Injectable & Oncology Trend Report. |
|
Report |
Feb 1, 2011 |
696 |
| Long-term aspirin cut colorectal cancer risk. |
Worcester, Sharon |
|
Feb 1, 2011 |
1015 |
| Reportlinker Adds The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact. |
|
|
Jan 27, 2011 |
705 |
| ASTRO Reaffirms Commitment to Quality, Issues Progress Report on Patient Safety Plan. |
|
|
Jan 26, 2011 |
666 |
| Reportlinker Adds Innovations in the Delivery of Cancer Therapies. |
|
|
Jan 25, 2011 |
667 |
| Research and Markets: Disease and Therapy Review 2011: Pancreatic Cancer. |
|
|
Jan 24, 2011 |
329 |
| Drug company links 'may have compromised cancer study in The Lancet'. |
|
|
Jan 21, 2011 |
413 |
| Reportlinker Adds Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market. |
|
|
Jan 20, 2011 |
674 |
| Research and Markets: Cervical Cancer Therapeutics Market Is Expected To Grow To $2.2 Billion by 2017 at A Compound Annual Growth Rate (CAGR) Of 5% between 2009 And 2016. |
|
|
Jan 18, 2011 |
1075 |
| Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium. |
|
|
Jan 17, 2011 |
498 |
| Research and Markets: Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report. |
|
Report |
Jan 12, 2011 |
559 |
| Women with advanced breast cancer who were treated with Roche Holding AG's (Basel CHE) Avastin were more likely to develop heart failure than other women, according to an analysis released last week that raised more concerns about the already troubled drug. |
|
|
Jan 10, 2011 |
346 |
| Avastin raises heart failure risk. |
|
|
Jan 5, 2011 |
549 |
| PSA test more reliable in men taking prostate-shrinking drug. |
|
|
Dec 18, 2010 |
718 |
| National Business Group on Health Launches Major Initiative to Address Cancer in the Workplace. |
|
|
Dec 16, 2010 |
991 |
| Drug Combination Shows Promise for Newly Diagnosed Blood Cancer Patients, Study Finds. |
|
|
Dec 9, 2010 |
817 |
| Elekta: Six-month Interim Report May - October 2010/11. |
|
|
Dec 8, 2010 |
682 |
| Better Treatment Adherence and Lower Health Costs for Cancer Patients Using nilotinib. |
|
|
Dec 7, 2010 |
717 |
| Osteoporosis drug improves survival in cancer patients. |
|
|
Dec 4, 2010 |
308 |
| The best natural breast cancer fighting combination I've ever seen. |
|
|
Dec 1, 2010 |
1045 |
| Updates on PET-CT and thyroid cancer. |
Lin, Frank I.; Iagaru, Andrei |
Clinical report |
Dec 1, 2010 |
3500 |
| New Study Finds Increased Tumor Growth Associated with Increased Delay in Seeking Skin Cancer Treatment. |
|
Clinical report |
Nov 12, 2010 |
786 |
| Research and Markets: Triple Analysis: Lung Cancer, Angiogenesis and Antibodies. |
|
|
Nov 12, 2010 |
705 |
| Research and Markets: Breast Cancer - Triple-Negative Breast Cancer Offers a Significant Opportunity to New Market Entrants while Herceptin Dominates the HER-2-Positive Market. |
|
|
Nov 9, 2010 |
599 |
| LifeSci Advisors Announces Investment Opinion on Genta Incorporated. |
|
|
Nov 9, 2010 |
1011 |
| Research and Markets: Competitor Analysis on Sphingosine-1-Phosphate (S1P) - S1P Inhibitors & Receptor Have Promise for the Treatment of Cancer. |
|
|
Nov 3, 2010 |
620 |
| New Deloitte Recap Report Identifies Strategies to Help Reduce Development Times and Increase Success Rates for Cancer Drugs. |
|
Report |
Nov 2, 2010 |
465 |
| HRT makes breast cancer more deadly: study. |
|
|
Nov 2, 2010 |
885 |
| Eli Lilly & Co (Indianapolis IN) and Merck KGaA's (Darmstadt DEU) Erbitux helped a group of cancer patients previously thought to be immune to the treatment in a study that contradicts earlier assumptions of the way the drug works in those with a genetic mutation. |
|
|
Nov 1, 2010 |
349 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Angiogenesis and Cancer Vaccines 2010 Provides Systems, Analytical and Strategic Support. |
|
|
Oct 27, 2010 |
676 |
| PSA Tests Cut Risk of Prostate Cancer Spreading to the Body. |
|
|
Oct 26, 2010 |
644 |
| Macmillan has shown the way we need to act to help cancer victims; Veronica German, the Liberal Democrats' health spokeswoman, explains why Wales needs a comprehensive cancer strategy. |
|
Disease/Disorder overview |
Oct 25, 2010 |
623 |
| Research and Markets: Disease and Therapy Review: Ovarian Cancer - Incidence, Prevalence and Mortality Numbers and Percentages for Major Countries Worldwide. |
|
|
Oct 21, 2010 |
338 |
| October Research Reports on Drugs and Biotechnology Published by MarketPublishers.com. |
|
|
Oct 19, 2010 |
459 |
| Low-dose aspirin protects against colorectal ca: benefits of daily use become evident after 1 year, and rise with up to 10 years of use. |
Worcester, Sharon |
|
Oct 15, 2010 |
595 |
| IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study. |
|
|
Oct 13, 2010 |
1193 |
